Can treatment increase the epidemic size?

Journal of Mathematical Biology

Volumn 72, Issue 1-2, 2016, Pages 343-361

  Xiao, Yanyu ^a   Brauer, Fred ^b   Moghadas, Seyed M ^a  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Drug resistance; Epidemic modelling; Final size relation; Reproduction numbers; Treatment

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL RESISTANCE; BASIC REPRODUCTION NUMBER; BIOLOGICAL MODEL; EPIDEMICS; HUMAN; INFLUENZA, HUMAN; MATHEMATICAL PHENOMENA; STATISTICS AND NUMERICAL DATA; TRANSMISSION;

ANTIVIRAL AGENTS; BASIC REPRODUCTION NUMBER; DRUG RESISTANCE, VIRAL; EPIDEMICS; HUMANS; INFLUENZA, HUMAN; MATHEMATICAL CONCEPTS; MODELS, BIOLOGICAL;

EID: 84952976653     PISSN: 03036812     EISSN: 14321416     Source Type: Journal    
DOI: 10.1007/s00285-015-0887-y     Document Type: Article

References (26)

1. Anderson R, May R (1992) Infectious diseases of humans. Oxford University Press, Oxford
2. Andersson D, Levin B (1999) The biological cost of antibiotic resistance. Curr Opinion Microbiol 2(5):489–493
3. Björkman J, Nagaev I, Berg O, Hughes D, Andersson DI (2000) Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287(5457):1479–1482
4. Brauer F, Castillo-Chavez C (2010) Mathematical models in population biology and epidemiology, 2nd edn. Springer, New York
5. Diekmann O, Heesterbeek J (2000) Mathematical epidemiology of infectious diseases. Wiley, Chichester
6. Domingo E, Holland J (1997) RNA virus mutations and fitness for survival. Ann Rev Microbiol 51:151–178
7. Halloran M, Hayden F, Yang Y, Longini JI, Monto A (2006) Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol 165(2):212–221
8. Hansen E, Day T (2011) Optimal antiviral treatment strategies and the effects of resistance. Proc Royal Soc B 278(1708):1082–1089
9. Keeling M, Rohani P (2008) Modelling infectious diseases in humans and animals. Princeton University Press, Princeton
10. Kermak W, McKendrick A (1927) A contribution to the mathematical theory of epidemics. Proc Royal Soc A 115(772):700–721
11. Kermak W, McKendrick A (1931) Contributions to the mathematical theory of epidemics. II. the problem of endemicity. Proc Royal Soc A 138(834):55–83
12. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden F, Sugaya N, Kawaoka Y (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364(9436):759–765
13. Lipsitch M, Cohen T, Murray M, Levin B (2007) Antiviral resistance and the control of pandemic influenza. PLoS Med 4(1):111–121
14. Liu R, Gourley S (2012) Resistance to larvicides in mosquito populations and how it could benefit malaria control. Eur J Appl Math 24(3):415–436
15. Maisnier-Patin S, Andersson D (2004) Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res Microbiol 155(5):360–369
16. Miller R (2011) Controlling the evolution of antibiotic resistance. Ph.D. Thesis
17. Moghadas S (2008) Management of drug resistance in the population: influenza as a case study. Proc Royal Soc B 275(1639):1163–1169
18. Moghadas S (2011) Emergence of resistance in influenza with compensatory mutations. Math Popul Stud 18:106–121
19. Moghadas S, Bowman C, Röst G, Fisman D, Wu J (2009) Post-exposure prophylaxis during pandemic outbreaks. BMC Med 7(73):1–10. doi:10.1186/1741-7015-7-73. http://www.biomedcentral.com/1741-7015/7/73
20. Moghadas S, Bowman C, Röst G, Wu J (2008) Population-wide emergence of antiviral resistance during pandemic influenza. PLoS One 3(3):e1839
21. Rimmelzwaan G, Berkhoff E, Nieuwkoop N, Smith D, Fouchier R, Osterhaus A (2005) Full restoration of viral fitness by multiple compensatory comutations in the nucleoprotein of influenza a virus cytotoxic T-lymphocyte escape mutants. J Gen Virol 86(Pt 6):1801–1805
22. Simonsen L, Viboud C, Grenfell B, Dushoff J, Jennings L, Smit M, Macken C, Hata M, Gog J, Miller M, Holmes E (2007) The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24(8):1811–1820
23. van den Driessche P, Zou X (2007) Modeling relapse in infectious diseases. Math Biosci 207(1):89–103
24. van den Driessche P, Watmough J (2002) Reproduction numbers and subthreshold endemic equilibria for compartmental models of disease transmission. Math Biosci 180(1–2):29–48
25. Ward P, Small I, Smith J, Suter J, Dutkowshi R (2005) Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55(Suppl 1):i5–i21
26. Xiao Y, Zou X (2013) On latencies in malaria infections and their impact on the disease dynamics. Math Biosci Eng 10(2):463–481